AMERICAN SOCIETY OF HEMATOLOGY

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2011–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	4	1
2024	—	5	1
2023	—	4	1
2020	—	1	1
2019	—	4	1
2018	—	4	1
2017	—	4	1
2016	—	4	1
2015	—	4	1
2014	—	4	1
2013	—	5	1
2012	—	4	1
2011	—	3	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.	—	53

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	52
SENATE	52
Centers For Disease Control & Prevention (CDC)	36
Food & Drug Administration (FDA)	36
Natl Institutes of Health (NIH)	36
Centers For Medicare and Medicaid Services (CMS)	33
Health Resources & Services Administration (HRSA)	23
Health & Human Services, Dept of (HHS)	15

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Medicare/Medicaid	Medicare/Medicaid	46
Budget/Appropriations	Budget/Appropriations	41
Pharmacy	Pharmacy	37
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	37
Health Issues	Health Issues	15
Insurance	Insurance	13

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 5178119th Congress

Sickle Cell Disease Comprehensive Care Act

2026 · third_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

HR 5178/S 721, Sickle Cell Disease Comprehensive Care Act

Client expense: — · Firm income: $40,000

Matched citations: HR 5178

S. 721119th Congress

Sickle Cell Disease Comprehensive Care Act

2026 · third_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

HR 5178/S 721, Sickle Cell Disease Comprehensive Care Act

Client expense: — · Firm income: $40,000

Matched citations: S 721

H.R. 5178119th Congress

Sickle Cell Disease Comprehensive Care Act

2026 · second_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

HR 5178/S 721, Sickle Cell Disease Comprehensive Care Act

Client expense: — · Firm income: $40,000

Matched citations: HR 5178

S. 721119th Congress

Sickle Cell Disease Comprehensive Care Act

2026 · second_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

HR 5178/S 721, Sickle Cell Disease Comprehensive Care Act

Client expense: — · Firm income: $40,000

Matched citations: S 721

Show 21 more cited filings

H.R. 5178119th Congress

Sickle Cell Disease Comprehensive Care Act

2026 · first_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

HR 5178/S 721, Sickle Cell Disease Comprehensive Care Act

Client expense: — · Firm income: $40,000

Matched citations: HR 5178

S. 721119th Congress

Sickle Cell Disease Comprehensive Care Act

2026 · first_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

HR 5178/S 721, Sickle Cell Disease Comprehensive Care Act

Client expense: — · Firm income: $40,000

Matched citations: S 721

H.R. 5178119th Congress

Sickle Cell Disease Comprehensive Care Act

2025 · fourth_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

HR 5178/S 721, Sickle Cell Disease Comprehensive Care Act

Client expense: — · Firm income: $40,000

Matched citations: HR 5178

S. 721119th Congress

Sickle Cell Disease Comprehensive Care Act

2025 · fourth_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

HR 5178/S 721, Sickle Cell Disease Comprehensive Care Act

Client expense: — · Firm income: $40,000

Matched citations: S 721

H.R. 1119th Congress

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2025 · third_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

HR 5178/S 721, Sickle Cell Disease Comprehensive Care Act; HR 2433, Reducing Medically Unnecessary Delays in Care Act of 2025; HR 1, One Big Beautiful Bill Act

Client expense: — · Firm income: $40,000

Matched citations: HR 1

H.R. 2433119th Congress

Reducing Medically Unnecessary Delays in Care Act of 2025

2025 · third_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

HR 5178/S 721, Sickle Cell Disease Comprehensive Care Act; HR 2433, Reducing Medically Unnecessary Delays in Care Act of 2025; HR 1, One Big Beautiful Bill Act

Client expense: — · Firm income: $40,000

Matched citations: HR 2433

H.R. 5178119th Congress

Sickle Cell Disease Comprehensive Care Act

2025 · third_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

HR 5178/S 721, Sickle Cell Disease Comprehensive Care Act; HR 2433, Reducing Medically Unnecessary Delays in Care Act of 2025; HR 1, One Big Beautiful Bill Act

Client expense: — · Firm income: $40,000

Matched citations: HR 5178

S. 721119th Congress

Sickle Cell Disease Comprehensive Care Act

2025 · third_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

HR 5178/S 721, Sickle Cell Disease Comprehensive Care Act; HR 2433, Reducing Medically Unnecessary Delays in Care Act of 2025; HR 1, One Big Beautiful Bill Act

Client expense: — · Firm income: $40,000

Matched citations: S 721

S. 721119th Congress

Sickle Cell Disease Comprehensive Care Act

2025 · second_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

S. 721 Sickle Cell Disease Comprehensive Care Act

Client expense: — · Firm income: $40,000

Matched citations: S. 721

S. 721119th Congress

Sickle Cell Disease Comprehensive Care Act

2025 · first_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

S. 721 Sickle Cell Disease Comprehensive Care Act

Client expense: — · Firm income: $40,000

Matched citations: S. 721

H.R. 7432118th Congress

Sickle Cell Disease Comprehensive Care Act

2024 · fourth_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

HR7432, Sickle Cell Disease Comprehensive Care Act; Social Security Disability Insurance Reform; Sickle Cell Disease - comprehensive care and cell and gene therapy model

Client expense: — · Firm income: $40,000

Matched citations: HR7432

H.R. 7432118th Congress

Sickle Cell Disease Comprehensive Care Act

2024 · third_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

HR7432, Sickle Cell Disease Comprehensive Care Act; Social Security Disability Insurance Reform; Sickle Cell Disease - comprehensive care and cell and gene therapy model

Client expense: — · Firm income: $40,000

Matched citations: HR7432

S. 4338118th Congress

Pay PCPs Act of 2024

2024 · third_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

Medicare Physician Payment Reform; S4338, Pay PCP's Act

Client expense: — · Firm income: $40,000

Matched citations: S4338

H.R. 7432118th Congress

Sickle Cell Disease Comprehensive Care Act

2024 · second_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

HR7432 Sickle Cell Disease Comprehensive Care Act; Social Security Disability Insurance Reform; Sickle Cell Disease - comprehensive care and cell and gene therapy model

Client expense: — · Firm income: $40,000

Matched citations: HR7432

S. 4338118th Congress

Pay PCPs Act of 2024

2024 · second_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

Medicare Physician Payment Reform; S4338, Pay PCP's Act

Client expense: — · Firm income: $40,000

Matched citations: S4338

H.R. 7432118th Congress

Sickle Cell Disease Comprehensive Care Act

2024 · first_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

HR7432 Sickle Cell Disease Comprehensive Care Act; Social Security Disability Insurance Reform; Sickle Cell Disease - comprehensive care and cell and gene therapy model

Client expense: — · Firm income: $40,000

Matched citations: HR7432

H.R. 7432118th Congress

Sickle Cell Disease Comprehensive Care Act

2024 · first_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

HR7432 Sickle Cell Disease Comprehensive Care Act; Social Security Disability Insurance Reform; Sickle Cell Disease - comprehensive care and cell and gene therapy model

Client expense: — · Firm income: $30,000

Matched citations: HR7432

H.R. 1672118th Congress

Sickle Cell Disease Comprehensive Care Act

2023 · fourth_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

S 996/ HR 1672 Sickle Cell Disease Comprehensive Care Act; HR 3884, Sickle Cell Disease and other Heritable Blood Disorders Research, Surveillance, Prevention and Treatment Act of 2023

Client expense: — · Firm income: $30,000

Matched citations: HR 1672

H.R. 3884118th Congress

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023

2023 · fourth_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

S 996/ HR 1672 Sickle Cell Disease Comprehensive Care Act; HR 3884, Sickle Cell Disease and other Heritable Blood Disorders Research, Surveillance, Prevention and Treatment Act of 2023

Client expense: — · Firm income: $30,000

Matched citations: HR 3884

S. 996118th Congress

Sickle Cell Disease Comprehensive Care Act

2023 · fourth_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

S 996/ HR 1672 Sickle Cell Disease Comprehensive Care Act; HR 3884, Sickle Cell Disease and other Heritable Blood Disorders Research, Surveillance, Prevention and Treatment Act of 2023

Client expense: — · Firm income: $30,000

Matched citations: S 996

H.R. 1672118th Congress

Sickle Cell Disease Comprehensive Care Act

2023 · third_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

S 996/ HR 1672 Sickle Cell Disease Comprehensive Care Act; HR 3884, Sickle Cell Disease and other Heritable Blood Disorders Research, Surveillance, Prevention and Treatment Act of 2023

Client expense: — · Firm income: $30,000

Matched citations: HR 1672

Source: Senate LDA

AMERICAN SOCIETY OF HEMATOLOGY — Lobbying Disclosure | Poliscope